Hem › Metastaserande cancer › Nevada
Kliniska studier för Metastaserande cancer i Nevada
10 studier för Metastaserande cancer söker deltagare vid platser i Nevada.
Städer i Nevada
Officiell studietext (engelska)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- OptumCare Cancer Care at Charleston, Las Vegas
- Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas
- Summerlin Hospital Medical Center, Las Vegas
- och 2 fler
RekryterarFas 2
Alla åldrar · Alla kön · Uppdaterad 2 okt. 2026 · NCT05564377Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Comprehensive Cancer Centers, Las Vegas
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT07562152Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Renown Health Medical Oncology, Reno
- Renown Regional Medical Center, Reno
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT07222800A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Renown Health Medical Oncology, Reno
- Renown Office of Clinical Research, Reno
- Renown Regional Medical Center, Reno
RekryterarFas 2/3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06989437A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Comprehensive Cancer Centers of Nevada, Las Vegas
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07218380A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- The Center of Hope, Reno
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07213804A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
- Research Site, Reno
RekryterarFas 3
Ålder 18 till 130 · Alla kön · Uppdaterad 8 sep. 2026 · NCT07647328A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Comprehensive Cancer Centers of Nevada, Las Vegas
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 8 sep. 2026 · NCT06119581A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
- Comprehensive Cancer Centers of Nevada, Las Vegas
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 28 aug. 2026 · NCT07029399A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
- Comprehensive Cancer Center of Nevada, Las Vegas
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 15 juli 2026 · NCT06657144Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.